MLANA and melanoma: Here, we investigated the Melan‐A (melanoma antigen A)/MART‐1 (melanoma antigen recognized by T‐cells‐1) protein that has been the focus of a number of clinical approaches designed to employ T‐cells for targeting melanoma 16, 17, 18, 19, 20, 21.